BREAST ADENOCARCINOMA
Clinical trials for BREAST ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BREAST ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for BREAST ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for slowing advanced breast cancer
Disease control OngoingThis large, late-stage trial is testing whether adding a new drug called entinostat to standard hormone therapy (exemestane) works better than the hormone therapy alone. It's for people whose hormone-sensitive, advanced breast cancer has continued to grow despite prior treatment.…
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Precision proton beams target breast cancer with fewer side effects
Disease control OngoingThis study is testing a shorter, more targeted form of radiation therapy using proton beams for patients with early-stage breast cancer. The goal is to see if this approach effectively controls the cancer while causing fewer side effects and better cosmetic results compared to tr…
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Major trial tests new weapon against breast cancer recurrence
Disease control OngoingThis large study tested whether adding the drug bevacizumab to standard chemotherapy helps prevent breast cancer from returning after surgery. It involved nearly 5,000 patients with breast cancer that had spread to lymph nodes or was at high risk of coming back. The goal was to s…
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test new Triple-Threat attack on tough cancers
Disease control OngoingThis early-stage study is testing the safety and best dose of a three-drug combination (entinostat, nivolumab, and ipilimumab) for people with advanced solid tumors that have spread and are hard to treat. The goal is to see if boosting the immune system with two drugs while using…
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Gene test spares thousands from unnecessary chemo
Disease control OngoingThis large study aimed to find the best treatment for women with a common type of early-stage breast cancer. It used a special gene test (Oncotype DX) to see if hormone therapy alone was just as good as hormone therapy plus chemotherapy for women with a mid-range test score. The …
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
Researchers gather data to close breast cancer care gap for transgender community
Knowledge-focused OngoingThis study aims to collect and analyze information about how breast cancer is found, treated, and what the outcomes are for transgender and gender-diverse people. Researchers are looking at past medical records from 125 people to better understand the unique experiences and chall…
Matched conditions: BREAST ADENOCARCINOMA
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC